Its a good question.
You really need to compare it to the current " gold " standard test which is CA125 to the combination of BD1 peptides and CA125.
The real win here is the test combined with CA125 has reduced the number of peptides required from 20 to 2, most posters have missed this fact IMO and the market clearly has, with a 91% sensitivity compared to CA125 on its own at 27%.
Adding 2 BD1 peptides to the CA125 test could see a very quick to market product IMO.
Its going to take time as they have just discovered they can do away with most of the peptides and get the same result by using CA125.
Ann: Positive Results from the BARD1 Autoantibody Assay, page-43
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.0¢ | $7.597K | 17.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 21334 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 8500 | 1 |
View Market Depth
| Last trade - 12.25pm 13/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |